Discovery of the inhibitor of DNA binding 1 as a novel marker for radioresistance in pancreatic cancer using genome-wide RNA-seq

Purpose/Objective(s): Discovery of genetic drivers of radioresistance is critical for developing novel therapeutic strategies to combine with radiotherapy of radioresistant PDAC. In this study, we used genome-wide RNA-seq to identify genes upregulated in generated radioresistant PDAC cell lines and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuniga, Oscar, Byrum, Stephanie, Wolfe, Adam R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771737/
https://www.ncbi.nlm.nih.gov/pubmed/36627902
http://dx.doi.org/10.20517/cdr.2022.60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771737/
https://www.ncbi.nlm.nih.gov/pubmed/36627902
http://dx.doi.org/10.20517/cdr.2022.60

Ejemplares similares